Full Text View
Tabular View
No Study Results Posted
Related Studies
Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma
This study is ongoing, but not recruiting participants.
Study NCT00400894   Information provided by ProteoSys AG
First Received: November 16, 2006   Last Updated: February 2, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer
Benign Prostatic Hyperplasia
Prostatic Intraepithelial Neoplasia
Additional conditions recognized in this trial
Carcinoma
Carcinoma in Situ
Hyperplasia
Prostatic Hyperplasia
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Pathologic Processes
Prostatic Diseases
Urogenital Neoplasms
Sponsors listed in this trial
ProteoSys AG
Charite University, Berlin, Germany
University Hospital Tuebingen
Medical Centre, Ludwigshafen, Germany
Medical University Innsbruck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services